PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsFirst 'money-back guarantee' IVF scheme launches in UK

BioNews

First 'money-back guarantee' IVF scheme launches in UK

Published 8 August 2014 posted in News and appears in BioNews 766

Author

Ari Haque

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

A fertility clinic in Manchester has launched a new scheme that will give a refund to patients who fail to have a baby after undertaking IVF treatment...

A fertility clinic in Manchester has launched a new scheme that will give a refund to patients who fail to have a baby after undertaking IVF treatment.

Manchester Fertility has partnered with Access Fertility, a company specialising in IVF payment planning, to offer the scheme. In order to qualify, patients must be 37 and under and use their own eggs. The scheme entitles patients to have up to 70 percent of their fees refunded if the treatment does not result in a live birth.

One cycle of IVF treatment costs around £3,000 to those unable to access NHS funding, with extra costs for additional services and the necessary drugs. However, despite the significant cost, the chances of conceiving after the first cycle of IVF is around 30 percent, depending on the age of the patient.

A 'shared risk' IVF treatment plan of the type that Manchester Fertility is offering will help reduce the financial strain and risk of non-conception placed on patients who elect for privately funded IVF.

Similar shared risk IVF treatment plans are already in place in the USA, but Manchester Fertility is the first clinic in the UK to launch such a package. Another such scheme will be rolled out at a clinic in Brighton, with schemes in London to follow.

Many UK patients choose to travel abroad to participate in a shared risk scheme. Access Fertility CEO Ash Carroll-Miller said in the last five years, 90 percent of the 600 UK patients who travelled to the USA's largest fertility clinic for treatment had enrolled under a refund deal.

Mr Carroll-Miller commented that 'We don't feel patients in the UK should have to leave the country to access this kind of offer and we're excited to be bringing our unique programme to them'.

Access Fertility and Manchester Fertility have made efforts to separate the financial and medical elements of the treatment. Access Fertility decides whether patients are able to take part in the scheme and is responsible for refunding fees, while Manchester Fertility receives payment from Access only for the treatment itself.

Manchester Fertility continues to conduct all medical assessments and treatments. It stressed that its treatment recommendations will remain the same whether or not a patient participates in the money-back scheme, and that it receives no fee or commission for referring patients to the scheme.

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
12 February 2021 • 2 minutes read

Concerns over 'no baby, no fee' programmes

by Bethany Muller

Campaigners have requested increased oversight over 'no baby, no fee' funding programmes offered by IVF clinics...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
19 April 2016 • 6 minutes read

The good, the bad and the ugly: compassion and corruption in the commercial baby business

by Dr Ëlo Luik

Are business and medicine hopelessly intertwined in fertility care, at (quite literally) the expense of the patient?...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
18 September 2014 • 3 minutes read

Some NHS commissioners paying twice as much for IVF

by Rebecca Carr

Research conducted by the campaign group Fertility Fairness has uncovered significant variations in the amount that NHS Clinical Commissioning Groups are paying for one cycle of IVF treatment....

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
25 July 2014 • 2 minutes read

Mid Essex: Only HIV and cancer patients could be eligible for IVF

by Ruth Retassie

Mid Essex Clinical Commissioning Group has proposed to limit access to IVF to cancer patients and HIV-positive men under its options for reform to the funding of its fertility services....

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
9 August 2013 • 2 minutes read

Fertility app offers to fund treatment for women who can't conceive

by Ruth Retassie

A fertility app has been launched that will help pay for treatment for women who are unable to conceive after ten months of using the program...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
24 January 2013 • 2 minutes read

IVF funding cuts spark access concerns

by Jess Ware

The number of publicly funded IVF cycles dropped by nearly 14 percent this financial year in the UK, an investigation by the GP magazine Pulse has revealed...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
7 December 2012 • 2 minutes read

UK couple 'too old' for publicly-funded IVF to sue the Health Secretary

by Ari Haque

A couple who was refused fertility treatment on the NHS for being 'too old' has said it intends to challenge the decision in the courts, arguing that the decision amounts to age discrimination....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Anger as York backtracks on IVF funding promise

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856